Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134810) titled 'Research on the Detection Value of Tissue-Based Detection Methods for Antibodies Related to Central Nervous System Demyelinating Diseases (MOGAD, NMOSD, and GFAPA)' on Oct. 21.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The Third Affiliated Hospital Sun Yat-sen University
Condition:
Central nervous system demyelinating diseases: Myelin oligodendrocyte glycoprotein IgG-related disease and autoimmune glial fibrillary acidic protein astrocytopathy
Intervention:
Gold Standard:Diagnostic results at patient inclusion/final diagnosis (discharge diagnosis), that is, the ...